CCL2 and COVID-19: Different reports have shown that COVID-19 is characterized by a dysfunctional immune response, which exacerbates the disease progression as result of a persistent inflammation associated with high peripheral levels of IL-1β, IL-6, TNF-α, MCP-1, and IP10 (22, 87–89).